Abstract:Previous studies have demonstrated that pretreatment with electroacupuncture (EA) at the zusanli/ST36 and sanyinjiao/SP6 acupoints prevents ovariectomy-induced osteoporosis in rats; however, the therapeutic effects of EA at the governor vessel (GV) and bladder meridian (BL) acupoints remain unclear. In the present study, the effects of EA at the GV4, GV6, BL20 and BL23 acupoints on the bones of ovariectomized (OVX) rats were investigated to identify the pathways that mediate the action of EA on the bones. A postmenopausal osteoporosis model was established by performing an ovariectomy in six-month-old female Sprague Dawley rats. Following the ovariectomy, EA treatment was administered once per day for 90 days, with an interval of 5 days per 10 days. The changes in the serum levels of estradiol (E2) and the bone turnover markers, osteocalcin (OC) and tartrate-resistant acid phosphatase 5b (TRACP 5b), were determined, while the bone mineral density (BMD) of the lumbar vertebra and the histomorphology of the femur were observed. Furthermore, the expression of osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL), which are involved in the OPG/RANKL pathway, were detected by ELISA. In addition, the protein expression levels of low-density lipoprotein receptor-related protein (LRP) 5, β-catenin and runt-related transcription factor (Runx) 2, which are involved in the Wnt/β-catenin signaling pathway, were detected by western blot analysis. The results revealed that the GV and BL EA treatment groups significantly increased the serum levels of E2 and OC, decreased the serum levels of TRACP 5b and increased the BMD of the lumbar vertebra when compared with the OVX group. With regard to the histomorphology of the bone tissue, an ordered arrangement and a slight thinning of the trabeculae, with no evident hairline fractures, was observed in the femurs following EA treatment in the OVX rats. Furthermore, histomorphological analysis revealed that EA treatment significantly increased the values of the bone histomorphometry indices, trabecular area percentage, trabecular thickness and trabecular number, and reduced the value of trabecular separation, as compared with the OVX group. In addition, the ratio of OPG/RANKL expression was significantly upregulated, and the expression levels of LRP5, β-catenin and Runx2 were significantly upregulated in the EA treatment groups. Therefore, these results demonstrated that long-term stimulation with EA treatment at the GV and BL acupoints was able to alleviate osteoporosis induced by an ovariectomy through regulating the OPG/RANKL and Wnt/β-catenin signaling pathways.

Efficacy and safety of odanacatib in the treatment of postmenopausal women with osteoporosis: a meta-analysis

Efficacy and Safety of Denosumab in Postmenopausal Women with Osteoporosis

Potential Role of Odanacatib in the Treatment of Postmenopausal Intervertebral Disc Degeneration

Advances in Cathepsin K inhibitor Odanacatib in treatment of osteoporosis

Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice.

Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial

Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats

Observation of the efficacy and safety of zoledronic and in postmenopausal osteoporosis

Efficacy and safety of zoledronic acid in the treatment of osteoporosis: A meta-analysis of randomized controlled trials

Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate

A HNMR-based metabonomics study of postmenopausal osteoporosis and intervention effects of Er-Xian Decoction in ovariectomized rats.

Assessment of the Impact of Zoledronic Acid on Ovariectomized Osteoporosis Model Using Micro-Ct Scanning

NVP-BHG712 against postmenopausal osteoporosis in mice by targeting Cathepsin K

A novel β-catenin-binding drug SAHPA1 in treatment of osteoporosis in ovariectomized mice

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice

Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis

Electroacupuncture at the Governor Vessel and Bladder Meridian Acupoints Improves Postmenopausal Osteoporosis Through Osteoprotegerin/rankl/rank and Wnt/β-catenin Signaling Pathways.

A Network Meta‐analysis on the Short‐term Efficacy and Adverse Events of Different Anti‐osteoporosis Drugs for the Treatment of Postmenopausal Osteoporosis

Protective Effect Of Acteoside On Ovariectomy-Induced Bone Loss In Mice

NVP-BHG712 alleviates ovariectomy-induced osteoporosis by modulating osteoclastogenesis

S-Allylmercapto-N-Acetylcysteine (ASSNAC) Attenuates Osteoporosis in Ovariectomized (OVX) Mice